Skip to content
CompanySight
Company No. NI626666 · Incorporated 15 Sep 2014

Eakin R&D Limited

Registered name: EAKIN R&D LIMITED

Part of Eakin Healthcare Group Ltd group

Eakin R&D Limited does not publish its revenue or profit. Its accounts to 31 Mar 2025 show net assets of -£9.9m and 38 employees.

Eakin R&D Limited did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Mar 2025 showed net assets of −£9.9m and 38 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Comber; we hold 3 years of its filed accounts.

Balance sheet onlySection M · Professional, scientific and technical activitiesSIC 72190Other research and experimental development on natural sciences and engineering
Status
Active
Location
Comber, Northern Ireland
Age
12 yrs · since 2014
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The Company's ultimate parent undertaking is Dunrogan Limited, a company incorporated in the Isle of”

Latest accounts · year to 31 Mar 2025

Key figures

Revenue not disclosed

Eakin R&D Limited’s accounts for the year to 31 Mar 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
38
Net assets
−£9.9m

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 202331 Mar 202431 Mar 2025
DisclosureNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)———
Profit (best available)———
Employees (average)424438
Ratios
Profit margin———
Growth (year on year)
Headcount growth—▲4.8%▼13.6%
Balance sheet — indirect signals, not revenue
Cash at bank£96.6k£59.4k£802k
Net assets−£6.1m−£7.6m−£9.9m
Fixed assets£440k£826k£2.3m
Current assets£1.4m£1m£1.2m
Debtors£1.3m£986k£425k
Deferred income£273k£722k£345k
SourceFullAccounts · bulk data Dec 2024FullAccounts · bulk data Dec 2024FullAccounts · bulk data Dec 2025
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£9.9m
Cash at bank
▲1250%
Now £802k
Headcount
▼14%
Now 38
Deferred income
▼52%
Now £345k
Fixed assets
▲183%
Now £2.3m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Eakin Healthcare Group Ltdultimate parent75–100%
  2. Eakin R&D Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025, from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.